» Articles » PMID: 33599835

Multisystem Inflammatory Syndrome in Children Related to COVID-19: a Systematic Review

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2021 Feb 18
PMID 33599835
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2 was recently published and termed pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome (in children) (MIS(-C)). We performed a systematic review and describe the epidemiological, clinical, and prognostic characteristics of 953 PIMS-TS/MIS(-C) cases in 68 records. Additionally, we studied the sensitivity of different case definitions that are currently applied. PIMS-TS/MIS(-C) presents at a median age of 8 years. Epidemiological enrichment for males (58.9%) and ethnic minorities (37.0% Black) is present. Apart from obesity (25.3%), comorbidities are rare. PIMS-TS/MIS(-C) is characterized by fever (99.4%), gastrointestinal (85.6%) and cardiocirculatory manifestations (79.3%), and increased inflammatory biomarkers. Nevertheless, 50.3% present respiratory symptoms as well. Over half of patients (56.3%) present with shock. The majority of the patients (73.3%) need intensive care treatment, including extracorporal membrane oxygenation (ECMO) in 3.8%. Despite severe disease, mortality is rather low (1.9%). Of the currently used case definitions, the WHO definition is preferred, as it is more precise, while encompassing most cases.Conclusion: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. However, mortality rate is low and short-term outcome favorable. Long-term follow-up of chronic complications and additional clinical research to elucidate the underlying pathogenesis is crucial. What is Known: • A novel pediatric inflammatory syndrome with multisystem involvement has been described in association with SARS-CoV-2. • To date, the scattered reporting of cases and use of different case definitions provides insufficient insight in the full clinical spectrum, epidemiological and immunological features, and prognosis. What is New: • This systematic review illustrates the heterogeneous spectrum of PIMS-TS/MIS(-C) and its epidemiological enrichment for males, adolescents, and racial and ethnic minorities. • Despite its severe presentation, overall short-term outcome is good. • The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.

Citing Articles

Progress on diagnosis and treatment of multisystem inflammatory syndrome in children.

Peng Z, Zhou G Front Immunol. 2025; 16:1551122.

PMID: 40046058 PMC: 11879827. DOI: 10.3389/fimmu.2025.1551122.


Detection of serum composition in pediatric inflammatory multisystem syndrome associated with SARS-CoV-2 and the response for the treatment by FTIR.

Depciuch J, Sieminska I, Jakubczyk P, Klebowski B, Ptak K, Szymonska I Sci Rep. 2025; 15(1):4669.

PMID: 39920293 PMC: 11805954. DOI: 10.1038/s41598-025-88976-4.


The Incidence and Clinical Characteristics of COVID-19 in Children With IBD During the Omicron Wave: A Single-Center Experience in China.

Li R, Chen P, Li H, Ren L, Cheng Y, Liu L Gastroenterol Res Pract. 2025; 2025:1868214.

PMID: 39850808 PMC: 11756934. DOI: 10.1155/grp/1868214.


Epidemiological characterization of COVID-19 in children under 18 years old in Mexico: an analysis of the pandemic.

Takane-Cabrera I, Ortega-Vargas F, Diaz-Torres I, Herrera-Gonzalez A, Villa A, Garcia-Leon M Front Pediatr. 2025; 12():1440107.

PMID: 39840319 PMC: 11745888. DOI: 10.3389/fped.2024.1440107.


Inflammatory Heart Disease in Multisystem Inflammatory Syndrome.

La Vecchia G, Del Buono M, Bonaventura A, Vecchie A, Moroni F, Sanna T Curr Cardiol Rep. 2025; 27(1):10.

PMID: 39775145 PMC: 11711706. DOI: 10.1007/s11886-024-02173-9.


References
1.
Regev T, Antebi M, Eytan D, Shachor-Meyouhas Y, Ilivitzki A, Butbul Aviel Y . Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection. Pediatr Infect Dis J. 2020; 39(8):e206-e207. DOI: 10.1097/INF.0000000000002804. View

2.
Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D . Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020; 20(6):689-696. PMC: 7158906. DOI: 10.1016/S1473-3099(20)30198-5. View

3.
Ng K, Kothari T, Bandi S, Bird P, Goyal K, Zoha M . COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection. J Med Virol. 2020; 92(11):2880-2886. PMC: 7362099. DOI: 10.1002/jmv.26206. View

4.
Trogen B, Gonzalez F, Shust G . COVID-19-Associated Myocarditis in an Adolescent. Pediatr Infect Dis J. 2020; 39(8):e204-e205. DOI: 10.1097/INF.0000000000002788. View

5.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View